Assisted Reproductive Technology Market Report: Trends, Forecast and Competitive Analysis to 2030

Assisted Reproductive Technology Trends and Forecast

The future of the global assisted reproductive technology market looks promising with opportunities in the fertility clinic, hospital, surgical center, and clinical research institute markets. The global assisted reproductive technology market is expected to reach an estimated $46.2 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rising prevalence of infertility rate, rapid technological advancements in assisted reproductive technology, and and growing awareness regarding infertility treatment.

A more than 150-page report is developed to help in your business decisions.

Assisted Reproductive Technology by Segment

The study includes a forecast for the global assisted reproductive technology by product, technology, end use industry, and region.

Assisted Reproductive Technology Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instrument
• Accessory & Disposable
• Reagents & Media

Assisted Reproductive Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• In Vitro-Fertilization
• Artificial Insemination
• Others

Assisted Reproductive Technology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Fertility Clinic
• Hospital
• Surgical Center
• Clinical Research Institute
• Others

Assisted Reproductive Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Assisted Reproductive Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies assisted reproductive technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the assisted reproductive technology companies profiled in this report include-

• Cosmos Biomedical
• Microm U.K.
• Coopersurgical
• Fujifilm Irvine Scientific
• Cryolab
• Vitrolife Ab
• European Sperm Bank
• Bloom Ivf Centre
• Merck
• Ferring B.V.

Assisted Reproductive Technology Market Insights

Lucintel forecasts that in vitro-fertilization will remain the larger segment over the forecast period due to reducing fertility rate, growing sedentary lifestyle, growing trend of delayed pregnancy and low cost of IVF procedure.

Within this market, fertility clinic will remain the largest segment due to growing prevalence of reproductive cases, rising unhealthy lifestyle, and increase in the number of fertility clinics.

Europe is expected to witness highest growth over the forecast period due to growing prevalence of infertility, increasing disposable incomes, and rising funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region.

Features of the Global Assisted Reproductive Technology Market

Market Size Estimates: Assisted reproductive technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Assisted reproductive technology market by various segments, such as by product, technology, end use industry and region in terms of($B).

Regional Analysis: Assisted reproductive technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, end use industries, and regions for the assisted reproductive technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the assisted reproductive technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the assisted reproductive technology market size?

Answer: The global assisted reproductive technology market is expected to reach an estimated $46.2 billion by 2030.

Q.2 What is the growth forecast for assisted reproductive technology market?

Answer: The global assisted reproductive technology market is expected to grow with a CAGR of 9.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the assisted reproductive technology market?

Answer: The major drivers for this market are rising prevalence of infertility rate, rapid technological advancements in assisted reproductive technology, and and growing awareness regarding infertility treatment.

Q4. What are the major segments for assisted reproductive technology market?

Answer: The future of the assisted reproductive technology market looks promising with opportunities in the fertility clinic, hospital, surgical center, and clinical research institute markets.

Q5. Who are the key assisted reproductive technology market companies?

Answer: Some of the key assisted reproductive technology companies are as follows:

• Cosmos Biomedical
• Microm U.K.
• CooperSurgical
• FUJIFILM Irvine Scientific
• Cryolab
• Vitrolife AB
• European Sperm Bank
• Bloom IVF Centre
• Merck
• Ferring B.V.

Q6. Which assisted reproductive technology market segment will be the largest in future?

Answer: Lucintel forecasts that in vitro-fertilization will remain the larger segment over the forecast period due to reducing fertility rate, growing sedentary lifestyle, growing trend of delayed pregnancy and low cost of IVF procedure.

Q7. In assisted reproductive technology market, which region is expected to be the largest in next 5 years?

Answer: Europe is expected to witness highest growth over the forecast period due to growing prevalence of infertility, increasing disposable incomes, and rising funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the assisted reproductive technology market by product (instrument, accessory & disposable, and reagents & media), technology (in vitro-fertilization, artificial insemination, and others), end use industry (fertility clinic, hospital, surgical center, clinical research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?